Evidence map›Paper›PMID 31164707›Full record

ArticleEuropean journal of clinical nutrition2019

Associations between serum lipophilic antioxidants levels and non-alcoholic fatty liver disease are moderated by adiposity.

Mohsen Mazidi, Inge Huybrechts, Andre Pascal Kengne

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Mohsen MazidiKey State Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Chaoyang, China. mazidi@chalmers.se.
Inge HuybrechtsInternational Agency for Research on Cancer, Nutrition and Metabolism Group, Lyon, France.
Andre Pascal KengneNon-Communicable Disease Research Unit, South African Medical Research Council and University of Cape Town, Cape Town, South Africa.
Centre International de Recherche sur le Cancer · FRInstitute of Genetics and Developmental Biology · CNUniversity of Cape Town · ZA

Funding

World Health Organization 001
6 · The paper itself

Abstract

We aimed to evaluate the association between serum lipophilic antioxidants and liver function and prevalent non-alcoholic fatty liver disease (NAFLD). The Nutrition and Health Examination Surveys data were used (randomly selected population, 2001 and 2006). A total of 9658 participants were included, of whom 44.6% had prevalent NAFLD. In adjusted logistic regression models, participants in the top quarter of vitamin A and E had 56% (95% confidence interval (95%CI): 45-68) and 34% (95%CI: 29-57) lower odds of NAFLD compared with participants in the bottom quarter. When levels of vitamin A changed from low (1.53) to high (1.95), the fatty liver index (FLI) in the low body mass index (BMI) category changed from 36.1 to 24.3. However, at the high BMI level, FLI changed from 84.3 to 65.1 suggesting that obesity modulates the effects of vitamin A on FLI. This study suggests a protective effect of antioxidants against NAFLD occurrence, which is likely modulated by adiposity. Given the cross-sectional design, our results need to be validated in prospective studies.

Indexed as

ObesityAdultAntioxidantsCross-Sectional StudiesFemaleHumansLipidsMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseNutrition SurveysUnited StatesAntioxidantsLipids

Identifiers

PMID31164707
OpenAlexW2948290724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.